中国P站

Adipose tissue; Inflammation; Insulin resistance; Brown Adipose Tissue (BAT); Gut microbiome; Adipokines; Metabolism; Obesity; Genetics; Aging

Introduction

Adipose tissue plays a significant role in metabolic function, with inflammation being a key driver of dysfunction [1].

Macrophage polarization within adipose tissue contributes to this inflammation, impacting insulin sensitivity and glucose homeostasis [1].

Brown Adipose Tissue (BAT) activation enhances energy expenditure and improves metabolic health [2].

Cold exposure and certain pharmacological agents can stimulate BAT activity [2].

Adipose tissue dysfunction contributes to insulin resistance and type 2 diabetes [3].

Factors like obesity and inflammation impair adipose tissue's ability to properly store and release lipids [3].

The gut microbiome influences adipose tissue metabolism and inflammation [4].

Specific gut bacteria can either promote or protect against obesity and related metabolic disorders [4].

Adipokines, hormones secreted by adipose tissue, are crucial in regulating energy balance and insulin sensitivity [5].

Dysregulation of adipokine secretion contributes to metabolic disease [5].

Physical activity and exercise improve adipose tissue metabolism and reduce inflammation [6].

Exercise promotes browning of white adipose tissue and increases energy expenditure [6].

Dietary interventions, such as calorie restriction and specific macronutrient ratios, can modulate adipose tissue function and improve metabolic health [7].

The type of fat consumed also influences adipose tissue inflammation [7].

Genetic factors contribute to individual differences in adipose tissue distribution and function [8].

Certain genes predispose individuals to obesity and related metabolic complications [8].

Aging affects adipose tissue metabolism and increases inflammation [9].

Age-related changes in adipose tissue contribute to the development of metabolic disorders in older adults [9].

Pharmacological interventions targeting adipose tissue inflammation and metabolism are under development [10].

These therapies aim to improve insulin sensitivity and reduce the risk of metabolic disease [10].

Description

Adipose tissue inflammation is a major factor in metabolic dysfunction, significantly impacting insulin sensitivity and glucose homeostasis [1]. Macrophage polarization, a key contributor to this inflammation within adipose tissue, highlights the intricate connections between immune responses and metabolic health [1]. Understanding the mechanisms behind this polarization is crucial for developing targeted therapies.

Brown Adipose Tissue (BAT) activation presents a promising avenue for enhancing energy expenditure and improving metabolic health [2]. Stimuli like cold exposure and specific pharmacological agents can activate BAT, leading to increased calorie burning and improved insulin sensitivity [2]. Research into BAT activation could lead to novel approaches for combating obesity and related metabolic disorders. Adipose tissue dysfunction is closely linked to insulin resistance and type 2 diabetes [3]. The ability of adipose tissue to effectively store and release lipids is compromised by factors such as obesity and inflammation, disrupting metabolic balance [3]. Further investigation into these mechanisms is essential for creating strategies to restore proper adipose tissue function.

The gut microbiome's influence on adipose tissue metabolism and inflammation cannot be overstated [4]. Specific gut bacteria can either promote or protect against obesity and associated metabolic disorders [4]. Modulating the gut microbiome through dietary or other interventions could offer a powerful tool for improving metabolic health. Adipokines, hormones secreted by adipose tissue, play a vital role in regulating energy balance and insulin sensitivity [5]. Dysregulation of adipokine secretion is a significant contributor to metabolic disease, highlighting the complex interplay between adipose tissue and systemic metabolism [5]. A deeper understanding of adipokine signaling pathways is necessary for developing effective therapeutic interventions.

Lifestyle interventions, particularly physical activity and exercise, have a positive impact on adipose tissue metabolism and inflammation [6]. Exercise promotes browning of white adipose tissue, which increases energy expenditure [6]. Dietary interventions, including calorie restriction and specific macronutrient ratios, can also modulate adipose tissue function and improve metabolic health [7]. The type of fat consumed can influence adipose tissue inflammation [7]. Furthermore, genetic factors play a role in individual variations in adipose tissue distribution and function [8]. Certain genes predispose individuals to obesity and related metabolic complications [8]. Aging brings changes to adipose tissue metabolism and increased inflammation, contributing to metabolic disorders in older adults [9]. Finally, pharmacological interventions are being developed to target adipose tissue inflammation and metabolism to improve insulin sensitivity and reduce metabolic disease risk [10].

Conclusion

Adipose tissue plays a crucial role in metabolic health, and its dysfunction is linked to various metabolic disorders. Inflammation within adipose tissue, driven by macrophage polarization, impairs insulin sensitivity and glucose homeostasis. Brown Adipose Tissue (BAT) activation, stimulated by cold exposure or pharmacological agents, enhances energy expenditure and improves metabolic health. Factors like obesity and inflammation disrupt adipose tissue's ability to properly store and release lipids, contributing to insulin resistance and type 2 diabetes. The gut microbiome influences adipose tissue metabolism, with specific bacteria promoting or protecting against obesity. Adipokines, hormones secreted by adipose tissue, regulate energy balance and insulin sensitivity. Their dysregulation contributes to metabolic disease. Physical activity and dietary interventions improve adipose tissue metabolism and reduce inflammation, while genetic factors and aging also influence adipose tissue function. Pharmacological interventions targeting adipose tissue are under development to improve insulin sensitivity and reduce metabolic disease risk.

References

1. 邪泻胁邪褉械谢褜 袛, 孝邪褉邪薪芯胁邪 袦, 袣芯胁邪谢械胁邪 袗 (2023) .Int J Mol Sci 24:15584.

   , ,

2. Bartelt A, Bruns O, Reimer R (2011) .Nat Med 17:200-20.

   , ,

3. Klöting N, Fasshauer M, Herbrig K (2010) .Obes Facts 3:40-7.

   , ,

4. Cani P, Amar J, Iglesias M (2007) .Diabetes 56:1761-72.

   , ,

5. 斜褘褔薪芯胁邪 袙, 楔邪屑芯胁邪 袨, 袠胁邪薪芯胁邪 袦 (2022) .Front Endocrinol (Lausanne) 13:881224.

   , ,

6. Stanford K, Lynes M, Takahashi H (2018) .Dis Model Mech 11:dmm032858.

   , ,

7. Riccardi G, Giosuè A, Calabrese I (2004) .Clin Nutr 23:447-56.

   , ,

8. Rankinen T, Zuberi A, Chagnon Y (2006) .Obesity (Silver Spring) 14:529-644.

   , ,

9. Kirkland J, Tchkonia T, Zhu Y (2017) .J Am Geriatr Soc 65:2297-2307.

   , ,

10. Park J, Kim J, Kim H (2021) .Int J Mol Sci 22:8840.

    , ,